ACTIVE

PHARMOVAN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

127,9 k €

-28.8% YoY

Gross margin

303,9 k €

-13.4% YoY

Equity

249,4 k €

+0.2% YoY

Workforce

1,5 ETP

0.0% YoY

What does PHARMOVAN do?

PHARMOVAN is a Public limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Leuven. It employs on average 1,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0439.974.380

Incorporation

27/12/1989

Legal form

Public limited company

Registered office

Aarschotsesteenweg 537
3012 Leuven · FlandreSee on map

Contributed capital

61 500,00 €

Latest accounts

31/12/2025

Average workforce

1,5 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2011		2010		2009		2008		2007
Income statement
Gross margin	303,9 k €	-13.4%	350,8 k €	+18.3%	296,6 k €	-6.7%	317,9 k €	+23.6%	257,3 k €	+7.1%	240,2 k €	+28.8%	186,6 k €	-21.2%	236,7 k €	+22.4%	193,4 k €	+0.5%	192,6 k €	+30.2%	147,9 k €	-8.2%	161,2 k €	-26.7%	219,8 k €	+28.5%	171 k €	+42.4%	120,1 k €	-22.3%	154,5 k €	+52.8%	101,2 k €	-48.2%	195,4 k €
EBITDA	169 k €	-24.2%	223 k €	+29.6%	172,1 k €	-17.7%	209,1 k €	+54.4%	135,4 k €	-15.5%	160,2 k €	+54.1%	104 k €	-27.6%	143,6 k €	+105%	70,2 k €	-12.1%	79,8 k €	+133%	34,3 k €	+33.8%	25,6 k €	-62.6%	68,6 k €	+98.6%	34,6 k €	+284%	-18,8 k €	-246%	12,9 k €	+131%	-41,9 k €	-139%	108,1 k €
Operating result	159,3 k €	-26.9%	218 k €	+40.5%	155,1 k €	-15.2%	182,9 k €	+68.4%	108,6 k €	-17.2%	131,1 k €	+76.3%	74,4 k €	-35.9%	115,9 k €	+169%	43,1 k €	-17.6%	52,3 k €	+14988%	-351 €	+98.3%	-20,9 k €	-147%	44,2 k €	+304%	11 k €	+129%	-38 k €	-5441%	711,3 €	+101%	-69,2 k €	-193%	74,1 k €
Net result	127,9 k €	-28.8%	179,6 k €	+22.1%	147 k €	-17.2%	177,6 k €	+38.5%	128,2 k €	-12.2%	146 k €	+62.1%	90,1 k €	-34.4%	137,3 k €	+121%	62,2 k €	-16.9%	74,8 k €	+170%	27,7 k €	+29.5%	21,4 k €	-60.6%	54,3 k €	+0.0%	54,2 k €	+477%	9,4 k €	+3053%	-318,3 €	+99.0%	-32,5 k €	-144%	73,5 k €
Balance sheet
Equity	249,4 k €	+0.2%	249 k €	+0.0%	248,9 k €	+0.0%	248,9 k €	+0.0%	248,8 k €	+0.0%	248,8 k €	+0.0%	248,8 k €	+0.0%	248,7 k €	-42.0%	428,4 k €	+0.0%	428,2 k €	+12.7%	380,1 k €	+7.9%	352,4 k €	+6.5%	331 k €	-53.6%	713,3 k €	+8.2%	659 k €	+1.4%	649,6 k €	-0.0%	650 k €	-4.8%	682,5 k €
Total assets	626,3 k €	-7.4%	676,7 k €	+7.2%	631,1 k €	-9.8%	699,6 k €	+18.9%	588,2 k €	-2.3%	602 k €	+8.2%	556,2 k €	-13.8%	645,5 k €	-13.4%	745,2 k €	+0.2%	743,7 k €	+3.1%	721 k €	+1.8%	708,1 k €	+3.4%	684,8 k €	-43.9%	1,2 M €	+2.0%	1,2 M €	+3.7%	1,2 M €	+0.2%	1,2 M €	+1.3%	1,1 M €
Cash	145,9 k €	-24.3%	192,7 k €	+3.7%	185,9 k €	-29.8%	264,7 k €	+59.4%	166,1 k €	-6.9%	178,4 k €	+27.2%	140,3 k €	-28.0%	194,8 k €	+19.4%	163,2 k €	+3.8%	157,1 k €	+34.4%	116,9 k €	+29.1%	90,6 k €	-39.2%	149,1 k €	-51.6%	308,2 k €	+8.7%	283,5 k €	+12.1%	252,8 k €	-34.0%	383,2 k €	-1.8%	390 k €
Debts	374,5 k €	-12.0%	425,5 k €	+12.0%	379,9 k €	-15.2%	448,2 k €	+32.9%	337,3 k €	-3.8%	350,7 k €	+15.0%	305 k €	-23.0%	395,9 k €	+25.1%	316,5 k €	+0.5%	315 k €	-7.5%	340,6 k €	-4.2%	355,4 k €	+6.0%	335,1 k €	-33.5%	503,9 k €	-6.4%	538,5 k €	+6.6%	504,9 k €	+0.5%	502,2 k €	+10.3%	455,3 k €
Other
Workforce	1,5 ETP	0.0%	1,5 ETP	0.0%	1,5 ETP	0.0%	1,5 ETP	0.0%	1,5 ETP	+50.0%	1,0 ETP	-9.1%	1,1 ETP	+1000%	0,1 ETP	-90.0%	1,0 ETP	-33.3%	1,5 ETP	-11.8%	1,7 ETP	0.0%	1,7 ETP	-29.2%	2,4 ETP	-4.0%	2,5 ETP	-3.8%	2,6 ETP	-7.1%	2,8 ETP	+7.7%	2,6 ETP	+36.8%	1,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 24 ended

Active mandates

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 20 mai 2021 · until 20 mai 2027 · 0536.437.813

Represented by Vandecasteele CAROLINE

Active

Norbert Vandecasteele

Director · since 20 mai 2021 · until 20 mai 2027

Active

Ended mandates

BVBA MANAGEMENT VANDECASTEELE CAROLINE

Managing director · since 14 janvier 2015 · until 14 janvier 2021

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Director · since 14 janvier 2015 · until 14 janvier 2021 · 0536.437.813

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 14 janvier 2015 · until 14 janvier 2021 · 0536.437.813

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 14 janvier 2015 · 0536.437.813

Ended

At this address

Other companies at this address

Company	CBE no.
NOVAPHAR● Active	0465.801.819

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/06/2026	03/06/2025	20/08/2024	17/08/2023	14/07/2022	03/08/2021
General meeting	23/05/2026	24/05/2025	25/05/2024	27/05/2023	28/05/2022	22/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/05/2026	03/06/2026	Dutch	PDF
Abridged model	31/12/2024	24/05/2025	03/06/2025	Dutch	PDF
Abridged model	31/12/2023	25/05/2024	20/08/2024	Dutch	PDF
Abridged model	31/12/2022	27/05/2023	17/08/2023	Dutch	PDF
Abridged model	31/12/2021	28/05/2022	14/07/2022	Dutch	PDF
Abridged model	31/12/2020	22/05/2021	03/08/2021	Dutch	PDF
Abridged model	31/12/2019	23/05/2020	02/09/2020	Dutch	PDF
Abridged model	31/12/2018	25/05/2019	21/08/2019	Dutch	PDF
Abridged model	31/12/2017	26/05/2018	08/08/2018	Dutch	PDF
Abridged model	31/12/2016	27/05/2017	08/08/2017	Dutch	PDF
Abridged model	31/12/2015	28/05/2016	30/06/2016	Dutch	PDF
Abridged model	31/12/2014	23/05/2015	15/06/2015	Dutch	PDF
Abridged model	30/09/2013	19/02/2014	13/03/2014	Dutch	PDF
Abridged model	30/09/2012	20/02/2013	31/05/2013	Dutch	PDF
Abridged model	30/09/2011	15/02/2012	24/05/2012	Dutch	PDF
Abridged model	30/09/2010	09/03/2011	23/08/2011	Dutch	PDF
Abridged model	30/09/2009	10/03/2010	29/04/2010	Dutch	PDF
Abridged model	30/09/2008	18/02/2009	24/04/2009	Dutch	PDF
Abridged model	30/09/2007	12/03/2008	25/04/2008	Dutch	PDF
Abridged model	30/09/2006	08/03/2007	10/05/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 24 ended

Active mandates

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 20 mai 2021 · until 20 mai 2027 · 0536.437.813

Represented by Vandecasteele CAROLINE

Active

Norbert Vandecasteele

Director · since 20 mai 2021 · until 20 mai 2027

Active

Ended mandates

BVBA MANAGEMENT VANDECASTEELE CAROLINE

Managing director · since 14 janvier 2015 · until 14 janvier 2021

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Director · since 14 janvier 2015 · until 14 janvier 2021 · 0536.437.813

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 14 janvier 2015 · until 14 janvier 2021 · 0536.437.813

Ended

MANAGEMENT CAROLINE VANDECASTEELE

Managing director · since 14 janvier 2015 · 0536.437.813

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other15/06/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL
PDF
Mandates04/11/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/02/2015
ONTSLAGEN - BENOEMINGEN
PDF
Registered office20/05/2014
MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates30/12/2013
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring21/01/2013
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring19/06/2012
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF
Capital / shares01/03/2012
KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025127,9 k €↓
2024
Annual accounts 2024179,6 k €↑
2023
Annual accounts 2023147 k €↓
2022
Annual accounts 2022177,6 k €↑
2021
Annual accounts 2021128,2 k €↓
2020
Annual accounts 2020146 k €↑
2019
Annual accounts 201990,1 k €↓
2018
Annual accounts 2018137,3 k €↑
2017
Annual accounts 201762,2 k €↓
2016
Annual accounts 201674,8 k €↑
2015
Annual accounts 201527,7 k €↑
2014
Annual accounts 201421,4 k €↓
2013
Annual accounts 201354,3 k €↑
2011
Annual accounts 201154,2 k €↑
2010
Annual accounts 20109,4 k €↑
2009
Annual accounts 2009-318,3 €↑
2008
Annual accounts 2008-32,5 k €↓
2007
Annual accounts 200773,5 k €
27/12/1989
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMOVAN

Overview

What does PHARMOVAN do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline